The U.S. FDA has approved Abbott Laboratories’ blood test that would help doctors assess traumatic brain injury (TBI), commonly known as concussions. This permission gives the first commercially available laboratory blood test for TBI, for helping the doctors to rule out need for a CT scan in patients with mild TBI.